SCHEMBL7145684

SCHEMBL7145684

COc1cc(OC)cc(Sc2ccc([N+](=O)[O-])cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.58
PTGS2 P35354 1/20 0.58
MAPT P10636 8/20 0.54
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
PIK3CA P42336 1/20 0.47
HIF1A Q16665 1/20 0.47
EPAS1 Q99814 1/20 0.47
HTT P42858 5/20 0.47
MAPK1 P28482 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
HPGD P15428 2/20 0.47
ALDH1A1 P00352 6/20 0.46
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
APP P05067 1/20 0.46
LMNA P02545 3/20 0.43
TLR9 Q9NR96 1/20 0.43
TDP1 Q9NUW8 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5791490 0.88 MAPT (0.59) PTGS1PTGS2MAPTMEN1KMT2A
SCHEMBL8866375 0.86 KMT2A (0.50) PTGS1PTGS2MAPTMEN1KMT2A
SCHEMBL4163474 0.80 MAPT (0.79) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL3328543 0.80 MAPT (0.79) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL7142272 0.78 MAPT (0.43) PTGS1PTGS2MAPTMEN1KMT2A
SCHEMBL811086 0.78 TSHR (0.49) PTGS1PTGS2MAPTMEN1KMT2A
SCHEMBL8934649 0.78 MAPT (0.76) MAPTMEN1KMT2AHTTMAPK1
Fluoride SCHEMBL29135589 0.78 MAPT (0.76) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL8934655 0.78 MAPT (0.76) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL7140685 0.77 MAPT (0.65) MAPTMEN1KMT2AHTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0930302-B1 Benzosulfone derivatives HOFFMANN LA ROCHE (CH) 2003-04-02 EP disclosed
US-5990105-A POSSESS A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; TREATING OR PREVENTING PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, DEPRESSIONS, NEUROLOGICAL DISORDERS, PARKINSON'S, AMYOTROPHIC LATERAL SCLEROSIS, ALZHEIMER'S AND HUNTINGTON'S DISEASE HOFFMANN-LA ROCHE INC. (US) 1999-11-23 US disclosed
EP-0930302-A2 Benzosulfone derivatives F.HOFFMANN-LA ROCHE AG (CH) 1999-07-21 EP disclosed